Browsing Tag
Tony Wood
4 posts
Canada approves GSK’s Arexvy vaccine for RSV protection in adults 50-59 at elevated risk
In a crucial development for public health, Health Canada has extended its approval for GlaxoSmithKline’s Arexvy vaccine to…
November 7, 2024
GSK to acquire Aiolos Bio to expand respiratory treatment portfolio
GSK plc (LSE/NYSE: GSK) and Aiolos Bio, Inc. (Aiolos) have announced a significant agreement, where GSK will acquire…
January 9, 2024
GSK gets Jesduvroq FDA approval for anaemia of chronic kidney disease
GSK has secured the approval of the US Food and Drug Administration (FDA) for the company’s Jesduvroq (daprodustat)…
February 4, 2023
Wave Life Sciences, GSK partner on oligonucleotide-based gene therapies
Wave Life Sciences and GSK have forged a partnership to discover and develop oligonucleotide therapeutics, focusing on new…
December 15, 2022